Peptic ulcer and Helicobacter pylori

References

• Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273–5
   PubMed Web of Science ®Google Scholar
• Susser M, Stein Z. Civilisation and peptic ulcer. Lancet 1962; 1: 115–9
   PubMed Web of Science ®Google Scholar
• Blaser MJ. Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet 1997; 349(9057): 1020–2
   PubMed Web of Science ®Google Scholar
• Sathar MA, Gouws E, Simjee AE, et al. Seroepidemiological study of Helicobacter pylori infection in South African children. Trans R Soc Top Med Hyg 1997; 91(4): 393–5
   Google Scholar
• Blaser MJ. Helicobacters are indigenous to the human stomach: duodenal ulceration is due to changes in gastric microecology in the modern era. Gut 1998; 43(5): 721–7
   PubMed Web of Science ®Google Scholar
• Susser M. Environmental factors and peptic ulcer. Practitioner 1962; 1 (Jan 20): 115–9
   Google Scholar
• Sonnenberg A. Occurrence of a cohort phenomenon in peptic ulcer mortality from Switzerland. Gastroenterology 1984; 86(3): 398–401
   Google Scholar
• Baron JH, Sonnenberg A. Hospital admissions for peptic ulcer and indigestion in London and New York in the 19th and early 20th centuries. Gut 2002; 50(4): 568–70
   Google Scholar
• Higham J, Kang JY, Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut 2002; 50(4): 460–4 [Erratum, Gut 2003; 52(3): 458]
   PubMed Web of Science ®Google Scholar
• Correa P, Schmidt BA. The relationship between gastric cancer frequency and the ratio of gastric to duodenal ulcer. Aliment Pharmacol Ther 1995; 9(Suppl 2): 13–9
   Google Scholar
• Hsieh CC, Tzonou A, Zavitsanos X, et al. Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk: a birth order study. Am J Epidemiol 1992; 136(9): 1115–21
   Google Scholar
• Ford AC, Delaney BC, Forman D, et al. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol 2004: 99(9): 1833–55
   PubMed Web of Science ®Google Scholar
• Roderick P, Davies R, Raftery J, et al. The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model. Health Technol Assess 2003; 7(6): 1–86
   PubMedGoogle Scholar
• Gisbert JP, Khorrami S, Carballo F, et al. Meta-analysis: Helicobacter pylori eradication therapy vs antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther 2004; 19(6): 617–29
   Google Scholar
• Sharma VK, Sahai AV, Corder FA, et al. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage. Aliment Pharmacol Ther 2001; 15(12): 1939–47
   Google Scholar
• American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 1998; 114(3): 579–81
   Google Scholar
• Malfertheiner P, Megraud F, O'Morain C, et al; European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection—the Maastricht 2–2000 Consensus Report. Aliment Pharmacol Ther 2002; 16(2): 167–80
   Google Scholar
• McColl KE, Murray LS, Gillen D, et al. Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia. BMJ 2002; 324(7344): 999–1002 [Errata, BMJ 2002; 325(7362): 479 and 2002; 325(7364): 580]
   Google Scholar
• Vaira D, Vakil N. Blood, urine, stool, breath, money, and Helicobacter pylori. Gut 2001; 48(3): 287–9
   PubMedGoogle Scholar
• Gatta L, Vakil N, Ricci C, et al. A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment. Aliment Pharmacol Ther 2003; 17(6): 793–8
   Google Scholar
• Ricci C, Gatta L, Tampieri A, et al. Accuracy of low dosage of 13C urea for diagnosis and monitoring Helicobacter pylori infection. (Abstr) Gastroenterology 2004; 126: S1276
   Google Scholar
• Vaira D, Malfertheiner P, Megraud F, et al. Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet 1999; 354(9172): 30–3
   Google Scholar
• Gisbert JP, Pajares JM. Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review. Helicobacter 2004; 9(4): 347–68
   PubMed Web of Science ®Google Scholar
• Gatta L, Perna F, Ricci C, et al. A rapid immunochromatographic assay for Helicobacter pylori in stool before and after treatment. Aliment Pharmacol Ther 2004; 20(4): 469–74
   Google Scholar
• Gene E, Calvet X, Azagra R, et al. Triple vs quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther 2003; 17(9): 1137–43
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Gonzalez L, Calvet X, et al. Helicobacter pylori eradication: proton pump inhibitor vs ranitidine bismuth citrate plus two antibiotics for 1 week—a meta-analysis of efficacy. Aliment Pharmacol Ther 2000; 14(9): 1141–50
   Google Scholar
• Katelaris PH, Forbes GM, Talley NJ, et al. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: the QUADRATE Study. Gastroenterology 2002; 123(6): 1763–9
   Google Scholar
• Meyer JM, Silliman NP, Wang W, et al. Risk factors for Helicobacter pylori resistance in the United States: the Surveillance of H pylori Antimicrobial Resistance Partnership (SHARP) study, 1993–1999. Ann Intern Med 2002; 136(1): 13–24
   PubMed Web of Science ®Google Scholar
• Best L, Cooper-Lesins G, Haldane D, et al. Helicobacter pylori antibiotic resistance in Canadian populations. (Abstr) Gastroenterology 2004, 126: S1293
   Google Scholar
• Zullo A, Vaira D, Vakil N, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther 2003; 17(5): 719–26 [Erratum, Aliment Pharmacol Ther 2003; 17(9): 1205]
   Google Scholar
• Nista EC, Candelli M, Fini L, et al. 10 days levofloxacin-based triple therapy in second line treatment for Helicobacter pylori eradication. (Abstr) Gastroenterology 2004; 126: S576
   PubMedGoogle Scholar
• Gatta L, Ricci C, Zullo A, et al. High eradication rate with a rescue levofloxacin based treatment for Helicobacter pylori. (Abstr) Gastroenterology 2004; 126: S574
   Google Scholar